Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical insulin for corneal epithelial healing after penetrating keratoplasty
TCTR20250622003Phase 2Not yet recruiting
- Sponsor
- Chiang Mai University
- Start
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of human insulin in Corneal epithelial defect, Post-Penetrating Keratoplasty State (Post-PKP), sponsored by Chiang Mai University. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
human insulin
03
Conditions
Corneal epithelial defectPost-Penetrating Keratoplasty State (Post-PKP)
Beyond the preview
Go deeper on TCTR20250622003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250622003.